<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38600563</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-5876</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of translational medicine</Title><ISOAbbreviation>J Transl Med</ISOAbbreviation></Journal><ArticleTitle>Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.</ArticleTitle><Pagination><StartPage>343</StartPage><MedlinePgn>343</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">343</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12967-024-05148-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Accumulating evidence suggests that autonomic dysfunction and persistent systemic inflammation are common clinical features in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID. However, there is limited knowledge regarding their potential association with circulating biomarkers and illness severity in these conditions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-site, prospective, cross-sectional, pilot cohort study aimed to distinguish between the two patient populations by using self-reported outcome measures and circulating biomarkers of endothelial function and systemic inflammation status. Thirty-one individuals with ME/CFS, 23 individuals with long COVID, and 31 matched sedentary healthy controls were included. All study participants underwent non-invasive cardiovascular hemodynamic challenge testing (10&#xa0;min NASA lean test) for assessment of orthostatic intolerance. Regression analysis was used to examine associations between outcome measures and circulating biomarkers in the study participants. Classification across groups was based on principal component and discriminant analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four ME/CFS patients (13%), 1 with long COVID (4%), and 1 healthy control (3%) presented postural orthostatic tachycardia syndrome (POTS) using the 10-min NASA lean test. Compared with matched healthy controls, ME/CFS and long COVID subjects showed higher levels of ET-1 (p&#x2009;&lt;&#x2009;0.05) and VCAM-1 (p&#x2009;&lt;&#x2009;0.001), and lower levels of nitrites (NOx assessed as NO<sub>2</sub><sup>-</sup> + NO<sub>3</sub><sup>-</sup>) (p&#x2009;&lt;&#x2009;0.01). ME/CFS patients also showed higher levels of serpin E1 (PAI-1) and E-selectin than did both long COVID and matched control subjects (p&#x2009;&lt;&#x2009;0.01 in all cases). Long COVID patients had lower TSP-1 levels than did ME/CFS patients and matched sedentary healthy controls (p&#x2009;&lt;&#x2009;0.001). As for inflammation biomarkers, both long COVID and ME/CFS subjects had higher levels of TNF-&#x3b1; than did matched healthy controls (p&#x2009;&lt;&#x2009;0.01 in both comparisons). Compared with controls, ME/CFS patients had higher levels of IL-1&#x3b2; (p&#x2009;&lt;&#x2009;0.001), IL-4 (p&#x2009;&lt;&#x2009;0.001), IL-6 (p&#x2009;&lt;&#x2009;0.01), IL-10 (p&#x2009;&lt;&#x2009;0.001), IP-10 (p&#x2009;&lt;&#x2009;0.05), and leptin (p&#x2009;&lt;&#x2009;0.001). Principal component analysis supported differentiation between groups based on self-reported outcome measures and biomarkers of endothelial function and inflammatory status in the study population.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings revealed that combining biomarkers of endothelial dysfunction and inflammation with outcome measures differentiate ME/CFS and Long COVID using robust discriminant analysis of principal components. Further research is needed to provide a more comprehensive characterization of these underlying pathomechanisms, which could be promising targets for therapeutic and preventive strategies in these conditions.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Domingo</LastName><ForeName>Joan Carles</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-6356-0836</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Barcelona, 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Battistini</LastName><ForeName>Federica</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7544-0938</Identifier><AffiliationInfo><Affiliation>Molecular Modelling and Bioinformatics Group, Institute for Research in Biomedicine, Barcelona Institute of Science and Technology, Barcelona, 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordobilla</LastName><ForeName>Bego&#xf1;a</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0418-9387</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Barcelona, 08028, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaragoz&#xe1;</LastName><ForeName>Maria Cleof&#xe9;</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0002-9797-0219</Identifier><AffiliationInfo><Affiliation>Clinical Research Department, Laboratorios Vi&#xf1;as, Barcelona, 08012, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanmartin-Senta&#xf1;es</LastName><ForeName>Ram&#xf3;n</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-6415-6368</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Clinical Unit in ME/CFS and Long COVID, Vall d'Hebron University Hospital, Universitat Aut&#xf2;noma de Barcelona, Barcelona, 08035, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Research Unit in ME/CFS and Long COVID, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, Barcelona, 08035, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alegre-Martin</LastName><ForeName>Jose</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7582-7585</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Clinical Unit in ME/CFS and Long COVID, Vall d'Hebron University Hospital, Universitat Aut&#xf2;noma de Barcelona, Barcelona, 08035, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Research Unit in ME/CFS and Long COVID, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, Barcelona, 08035, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cambras</LastName><ForeName>Trinitat</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9009-4690</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, 08028, Spain. cambras@ub.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Castro-Marrero</LastName><ForeName>Jesus</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2481-3052</Identifier><AffiliationInfo><Affiliation>Division of Rheumatology, Research Unit in ME/CFS and Long COVID, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, Barcelona, 08035, Spain. jesus.castro@vhir.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PI19/00731</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant><Grant><GrantID>PI19/00629</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Transl Med</MedlineTA><NlmUniqueID>101190741</NlmUniqueID><ISSNLinking>1479-5876</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">Endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">Post-exertional malaise</Keyword></KeywordList><CoiStatement>The authors declare no conflict of financial or non-financial interests. The funders had no role in the design of the study, in the collection, analysis or interpretation of data, in the writing of the manuscript or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>11</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>23</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38600563</ArticleId><ArticleId IdType="pmc">PMC11005215</ArticleId><ArticleId IdType="doi">10.1186/s12967-024-05148-0</ArticleId><ArticleId IdType="pii">10.1186/s12967-024-05148-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA. 2015;313:1101&#x2013;2. doi: 10.1001/jama.2015.1346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolou E, Rizwan M, Moustardas P, Sjogren P, Bertilson BC, Bragee B, Polo O, Rosen A. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome. Front Immunol. 2022;13:949787. doi: 10.3389/fimmu.2022.949787.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.949787</ArticleId><ArticleId IdType="pmc">PMC9630598</ArticleId><ArticleId IdType="pubmed">36341457</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JS, Lacerda EM, Nacul L, Kingdon CC, Norris J, O&#x2019;Boyle S, Roberts CH, Palla L, Riley EM, Cliff JM. Salivary DNA loads for human herpesviruses 6 and 7 are correlated with Disease phenotype in myalgic Encephalomyelitis/Chronic fatigue syndrome. Front Med (Lausanne) 2021;8:656692. doi: 10.3389/fmed.2021.656692.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.656692</ArticleId><ArticleId IdType="pmc">PMC8378328</ArticleId><ArticleId IdType="pubmed">34422848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr J. Early Growth Response Gene Upregulation in Epstein-Barr Virus (EBV)-Associated myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS). Biomolecules. 2020;10. 10.3390/biom10111484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692278</ArticleId><ArticleId IdType="pubmed">33114612</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;7. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Dorri JA. ME/CFS and Post-exertional Malaise among patients with long COVID. Neurol Int. 2022;15:1&#x2013;11. doi: 10.3390/neurolint15010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15010001</ArticleId><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long CC. Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, Blyuss O, Bobkova P, Bonsel G, Borzakova S, Buonsenso D, Butnaru D, Carter A, Chu H, De Rose C, Diab MM, Ekbom E, El Tantawi M, Fomin V, Frithiof R, Gamirova A, Glybochko PV, Haagsma JA, Haghjooy Javanmard S, Hamilton EB, Harris G, Heijenbrok-Kal MH, Helbok R, Hellemons ME, Hillus D, Huijts SM, Hultstrom M, Jassat W, Kurth F, Larsson IM, Lipcsey M, Liu C, Loflin CD, Malinovschi A, Mao W, Mazankova L, McCulloch D, Menges D, Mohammadifard N, Munblit D, Nekliudov NA, Ogbuoji O, Osmanov IM, Penalvo JL, Petersen MS, Puhan MA, Rahman M, Rass V, Reinig N, Ribbers GM, Ricchiuto A, Rubertsson S, Samitova E, Sarrafzadegan N, Shikhaleva A, Simpson KE, Sinatti D, Soriano JB, Spiridonova E, Steinbeis F, Svistunov AA, Valentini P, van de Water BJ, van den Berg-Emons R, Wallin E, Witzenrath M, Wu Y, Xu H, Zoller T, Adolph C, Albright J, Amlag JO, Aravkin AY, Bang-Jensen BL, Bisignano C, Castellano R, Castro E, Chakrabarti S, Collins JK, Dai X, Daoud F, Dapper C, Deen A, Duncan BB, Erickson M, Ewald SB, Ferrari AJ, Flaxman AD, Fullman N, Gamkrelidze A, Giles JR, Guo G, Hay SI, He J, Helak M, Hulland EN, Kereselidze M, Krohn KJ, Lazzar-Atwood A, Lindstrom A, Lozano R, Malta DC, Mansson J, Mantilla Herrera AM, Mokdad AH, Monasta L, Nomura S, Pasovic M, Pigott DM, Reiner RC, Reinke G, Ribeiro ALP, Santomauro DF, Sholokhov A, Spurlock EE, Walcott R, Walker A, Wiysonge CS, Zheng P, Bettger JP, Murray CJL, Vos T. JAMA. 2022;328:1604&#x2013;15. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Filgueiras IS, Kedor C, Freitag H, Wittke K, Bauer S, Sepulveda N, Mathias da Fonseca DL, Baiocchi GC, Marques AHC, Kim M, Lange T, Placa DR, Luebber F, Paulus FM, De Vito R, Jurisica I, Schulze-Forster K, Paul F, Bellmann-Strobl J, Rust R, Hoppmann U, Shoenfeld Y, Riemekasten G, Heidecke H, Cabral-Marques O, Scheibenbogen C. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity. Front Immunol. 2022;13:981532. doi: 10.3389/fimmu.2022.981532.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.981532</ArticleId><ArticleId IdType="pmc">PMC9552223</ArticleId><ArticleId IdType="pubmed">36238301</ArticleId></ArticleIdList></Reference><Reference><Citation>Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, Hanitsch L, Wittke K, Bauer S, Konietschke F, Paul F, Bellmann-Strobl J, Kedor C, Scheibenbogen C, Sotzny F. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J Transl Med. 2022;20:138. doi: 10.1186/s12967-022-03346-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03346-2</ArticleId><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H, Szklarski M, Lorenz S, Sotzny F, Bauer S, Philippe A, Kedor C, Grabowski P, Lange T, Riemekasten G, Heidecke H, Scheibenbogen C. Autoantibodies to vasoregulative G-Protein-coupled receptors correlate with Symptom Severity, autonomic dysfunction and disability in myalgic Encephalomyelitis/Chronic fatigue syndrome. J Clin Med. 2021;10. 10.3390/jcm10163675.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, Scheibenbogen C. European Network on MC. Myalgic Encephalomyelitis/Chronic fatigue syndrome - evidence for an autoimmune disease. Autoimmun Rev. 2018;17:601&#x2013;9. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L, Li J, Hornig M, Lipkin WI, Ruppert D, Hanson MR. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls. J Transl Med. 2023;21:322. doi: 10.1186/s12967-023-04179-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04179-3</ArticleId><ArticleId IdType="pmc">PMC10182359</ArticleId><ArticleId IdType="pubmed">37179299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsilingiris D, Vallianou NG, Karampela I, Christodoulatos GS, Papavasileiou G, Petropoulou D, Magkos F, Dalamaga M. Laboratory findings and biomarkers in long COVID: what do we know so far? Insights into Epidemiology, Pathogenesis, Therapeutic perspectives and challenges. Int J Mol Sci. 2023;24. 10.3390/ijms241310458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10341908</ArticleId><ArticleId IdType="pubmed">37445634</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, Neganova ME, Klochkov SG, Amjad Kamal M, Staines DR, Marshall-Gradisnik S. Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J Adv Res. 2022;40:179&#x2013;96. doi: 10.1016/j.jare.2021.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K. Orthostatic intolerance and chronotropic incompetence in patients with myalgic encephalomyelitis or chronic fatigue syndrome. Circ Rep. 2023;5:55&#x2013;61. doi: 10.1253/circrep.CR-22-0114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circrep.CR-22-0114</ArticleId><ArticleId IdType="pmc">PMC9908528</ArticleId><ArticleId IdType="pubmed">36818521</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne) 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, Staines D, Powles AC, Speight N, Vallings R, Bateman L, Baumgarten-Austrheim B, Bell DS, Carlo-Stella N, Chia J, Darragh A, Jo D, Lewis D, Light AR, Marshall-Gradisnik S, Mena I, Mikovits JA, Miwa K, Murovska M, Pall ML, Stevens S. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270:327&#x2013;38. doi: 10.1111/j.1365-2796.2011.02428.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S, Bourne KM, Stiles LE, Grubb BP, Fedorowski A, Stewart JM, Arnold AC, Pace LA, Axelsson J, Boris JR, Moak JP, Goodman BP, Chemali KR, Chung TH, Goldstein DS, Diedrich A, Miglis MG, Cortez MM, Miller AJ, Freeman R, Biaggioni I, Rowe PC, Sheldon RS, Shibao CA, Systrom DM, Cook GA, Doherty TA, Abdallah HI, Darbari A, Raj SR. Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National institutes of Health Expert Consensus Meeting - Part 1. Auton Neurosci. 2021;235:102828. doi: 10.1016/j.autneu.2021.102828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102828</ArticleId><ArticleId IdType="pmc">PMC8455420</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Cambras T, Castro-Marrero J, Zaragoza MC, Diez-Noguera A, Alegre J. Circadian rhythm abnormalities and autonomic dysfunction in patients with chronic fatigue Syndrome/Myalgic encephalomyelitis. PLoS ONE. 2018;13:e0198106. doi: 10.1371/journal.pone.0198106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0198106</ArticleId><ArticleId IdType="pmc">PMC5991397</ArticleId><ArticleId IdType="pubmed">29874259</ArticleId></ArticleIdList></Reference><Reference><Citation>Cambras T, Zeron-Rugerio MF, Diez-Noguera A, Zaragoza MC, Domingo JC, Sanmartin-Sentanes R, Alegre-Martin J, Castro-Marrero J. Skin temperature circadian rhythms and dysautonomia in myalgic Encephalomyelitis/Chronic fatigue syndrome: the role of Endothelin-1 in the vascular tone Dysregulation. Int J Mol Sci. 2023;24. 10.3390/ijms24054835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10003028</ArticleId><ArticleId IdType="pubmed">36902264</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Vernon SD, Jeys P, Ali W, Campos A, Unutmaz D, Yellman B, Bateman L. Hemodynamics during the 10-minute NASA lean test: evidence of circulatory decompensation in a subset of ME/CFS patients. J Transl Med. 2020;18:314. doi: 10.1186/s12967-020-02481-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02481-y</ArticleId><ArticleId IdType="pmc">PMC7429890</ArticleId><ArticleId IdType="pubmed">32799889</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Bourne KM, Stiles LE, Miglis MG, Cortez MM, Miller AJ, Freeman R, Biaggioni I, Rowe PC, Sheldon RS, Shibao CA, Diedrich A, Systrom DM, Cook GA, Doherty TA, Abdallah HI, Grubb BP, Fedorowski A, Stewart JM, Arnold AC, Pace LA, Axelsson J, Boris JR, Moak JP, Goodman BP, Chemali KR, Chung TH, Goldstein DS, Darbari A, Vernino S. Postural orthostatic tachycardia syndrome (POTS): priorities for POTS care and research from a 2019 National institutes of Health Expert Consensus Meeting - Part 2. Auton Neurosci. 2021;235:102836. doi: 10.1016/j.autneu.2021.102836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102836</ArticleId><ArticleId IdType="pmc">PMC8455430</ArticleId><ArticleId IdType="pubmed">34246578</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj SR, Arnold AC, Barboi A, Claydon VE, Limberg JK, Lucci VM, Numan M, Peltier A, Snapper H, Vernino S, American Autonomic S. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31:365&#x2013;8. doi: 10.1007/s10286-021-00798-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00798-2</ArticleId><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(Suppl 1):S79&#x2013;83. doi: 10.1093/clinids/18.supplement_1.s79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/18.supplement_1.s79</ArticleId><ArticleId IdType="pubmed">8148458</ArticleId></ArticleIdList></Reference><Reference><Citation>Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213. doi: 10.1016/0165-1781(89)90047-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry. 2003;25:277&#x2013;83. doi: 10.1016/s0163-8343(03)00043-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0163-8343(03)00043-4</ArticleId><ArticleId IdType="pubmed">12850660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sletten, Suarez, Low, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87:1196&#x2013;201. doi: 10.1016/j.mayocp.2012.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrezenmaier C, Gehrking JA, Hines SM, Low PA, Benrud-Larson LM, Sandroni P. Evaluation of orthostatic hypotension: relationship of a new self-report instrument to laboratory-based measures. Mayo Clin Proc. 2005;80:330-4. 10.4065/80.3.330.</Citation><ArticleIdList><ArticleId IdType="pubmed">15757013</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso J, Prieto L, Anto JM. [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results] Med Clin (Barc) 1995;104:771&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7783470</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y, Horikoshi M, Li W. Ggfortify: unified interface to visualize statistical results of popular R packages. R J. 2016;8:478&#x2013;89. doi: 10.32614/RJ-2016-060.</Citation><ArticleIdList><ArticleId IdType="doi">10.32614/RJ-2016-060</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivoto T, Lucio ADC. Metan: an R package for multi-environment trial analysis. Methods Ecol Evol. 2020;11:783&#x2013;9. doi: 10.1111/2041-210X.13384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2041-210X.13384</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall-Gradisnik S, Eaton-Fitch N. Understanding myalgic encephalomyelitis. Science. 2022;377:1150&#x2013;1. doi: 10.1126/science.abo1261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abo1261</ArticleId><ArticleId IdType="pubmed">36074854</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Med (Kaunas). 2021;57. 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilis P, Sagris M, Oikonomou E, Antonopoulos AS, Siasos G, Tsioufis C, Tousoulis D. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines. 2021;9. 10.3390/biomedicines9070781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8301477</ArticleId><ArticleId IdType="pubmed">34356845</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilis P, Sagris M, Antonopoulos AS, Oikonomou E, Tsioufis C, Tousoulis D. Inflammatory mediators of platelet activation: focus on atherosclerosis and COVID-19. Int J Mol Sci. 2021;22. 10.3390/ijms222011170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8539848</ArticleId><ArticleId IdType="pubmed">34681830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CC, Pan CS, Wang CY, Liu SW, Hsiao LD, Yang CM. Tumor necrosis factor-alpha induces VCAM-1-mediated inflammation via c-Src-dependent transactivation of EGF receptors in human cardiac fibroblasts. J Biomed Sci. 2015;22:53. doi: 10.1186/s12929-015-0165-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-015-0165-8</ArticleId><ArticleId IdType="pmc">PMC4502472</ArticleId><ArticleId IdType="pubmed">26173590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LMC, Wintjens MSJN, Nagy M, Willems L, Ten Cate H, Spronk HMH, van Kuijk SMJ, Ghossein-Doha C, Netea MG, Groh LA, van Petersen AS, Warl&#xe9; MC. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection. Front Immunol. 2023;14:1182182. doi: 10.3389/fimmu.2023.1182182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1182182</ArticleId><ArticleId IdType="pmc">PMC10586198</ArticleId><ArticleId IdType="pubmed">37868959</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45:27&#x2013;37. doi: 10.1097/AIA.0b013e318034194e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AIA.0b013e318034194e</ArticleId><ArticleId IdType="pmc">PMC2785020</ArticleId><ArticleId IdType="pubmed">17426506</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow GB, Whyte CS, Mutch NJ. A Serpin with a finger in many PAIs: PAI-1&#x2019;s central function in Thromboinflammation and Cardiovascular Disease. Front Cardiovasc Med. 2021;8:653655. doi: 10.3389/fcvm.2021.653655.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.653655</ArticleId><ArticleId IdType="pmc">PMC8085275</ArticleId><ArticleId IdType="pubmed">33937363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250&#x2013;6. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, Bosurgi L, Dutzmann J, Sedding D, Frese T, Girndt M, Holl JI, Gekle M, Mikolajczyk R, Binder M. The IL-1beta, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3:100663. doi: 10.1016/j.xcrm.2022.100663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M, Yan X, Jiang Y, Jin Z, Zhu S, Zou L, Liu Y, Zheng Q, Chen G, Gu R, Zhou Z, Han X, He J, Yin S, Ma C, Xiao W, Zeng Y, Chen F, Zhu Y. Endothelial biomarkers in patients recovered from COVID-19 one year after Hospital Discharge: a cross-sectional study. Mediterr J Hematol Infect Dis. 2022;14:e2022033. doi: 10.4084/MJHID.2022.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.4084/MJHID.2022.033</ArticleId><ArticleId IdType="pmc">PMC9084173</ArticleId><ArticleId IdType="pubmed">35615329</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Kim SY. Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics. Exp Mol Med. 2023;55:1&#x2013;12. doi: 10.1038/s12276-022-00906-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00906-w</ArticleId><ArticleId IdType="pmc">PMC9898542</ArticleId><ArticleId IdType="pubmed">36599934</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023;44:695&#x2013;709. doi: 10.1038/s41401-022-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-022-00998-0</ArticleId><ArticleId IdType="pmc">PMC9574180</ArticleId><ArticleId IdType="pubmed">36253560</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfera A, Osorio C, Del Campo ZM, Pereida CM, Maurer S, Maldonado S, Kozlakidis JC. Endothelial senescence and chronic fatigue syndrome, a COVID-19 based hypothesis. Front Cell Neurosci. 2021;15:673217. doi: 10.3389/fncel.2021.673217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.673217</ArticleId><ArticleId IdType="pmc">PMC8267916</ArticleId><ArticleId IdType="pubmed">34248502</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;8. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Frisoni P, Neri M, D&#x2019;Errico S, Alfieri L, Bonuccelli D, Cingolani M, Di Paolo M, Gaudio RM, Lestani M, Marti M, Martelloni M, Moreschi C, Santurro A, Scopetti M, Turriziani O, Zanon M, Scendoni R, Frati P, Fineschi V. Cytokine storm and histopathological findings in 60 cases of COVID-related death: from viral load research to immunohistochemical quantification of major players IL-1beta, IL-6, IL-15 and TNF-alpha. Forensic Sci Med Pathol. 2022;18:4&#x2013;19. doi: 10.1007/s12024-021-00414-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12024-021-00414-9</ArticleId><ArticleId IdType="pmc">PMC8406387</ArticleId><ArticleId IdType="pubmed">34463916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagashima S, Mendes MC, Camargo Martins AP, Borges NH, Godoy TM, Miggiolaro A, da Silva Deziderio F, Machado-Souza C, de Noronha L. Endothelial dysfunction and thrombosis in patients with COVID-19-Brief report. Arterioscler Thromb Vasc Biol. 2020;40:2404&#x2013;7. doi: 10.1161/ATVBAHA.120.314860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314860</ArticleId><ArticleId IdType="pmc">PMC7505138</ArticleId><ArticleId IdType="pubmed">32762443</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, O&#x2019;Boyle S, Palla L, Nacul FE, Mudie K, Kingdon CC, Cliff JM, Clark TG, Dockrell HM, Lacerda EM. How myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS. Front Neurol. 2020;11:826. doi: 10.3389/fneur.2020.00826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbitt M, Eaton-Fitch N, Staines D, Cabanas H, Marshall-Gradisnik S. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID) BMC Neurol. 2019;19:207. doi: 10.1186/s12883-019-1433-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1433-0</ArticleId><ArticleId IdType="pmc">PMC6708220</ArticleId><ArticleId IdType="pubmed">31445522</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez LS, Gutierrez J. Thrombospondin 1 in metabolic diseases. Front Endocrinol (Lausanne) 2021;12:638536. doi: 10.3389/fendo.2021.638536.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.638536</ArticleId><ArticleId IdType="pmc">PMC8040975</ArticleId><ArticleId IdType="pubmed">33854480</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogan S, Okuyan HM, Bal T, &#xc7;abalak M, Begen MA. Relationship of thrombospondin-1 and thrombospondin-2 with hematological, biochemical and inflammatory markers in COVID-19 patients. Turkish J Biochem. 2023;48:368&#x2013;75. doi: 10.1515/tjb-2022-0265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/tjb-2022-0265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>